Intra-Arterial) 7 patients with ≥70 mL ischemic core volume Background and Purpose-Endovascular therapy (EVT) is strongly recommended for acute cerebral large vessel occlusion with the Alberta Stroke Program Early CT Score (ASPECTS) ≥6 due to occlusion of the internal carotid artery or M1 segment of the middle cerebral artery. However, the effect of EVT for patients who have ischemic core with ASPECTS ≤5 (0-5) was not established. The purpose of this study was to elucidate the outcomes of EVT for patients with large ischemic core. Methods-Based on the data of The Recovery by Endovascular Salvage for Cerebral Ultra-Acute Embolism Japan Registry 2, patients with internal carotid artery or M1 segment of the middle cerebral artery occlusion and pretreatment ASPECTS 0 to 5 on noncontrast CT or diffusion-weighted image were extracted, and the outcomes by EVT were analyzed. Primary end point was defined as a good functional outcome (modified Rankin Scale score of ≤2) after 90 days. Result-Among 2420 registered patients, 504 patients were with internal carotid artery or M1 segment of the middle cerebral artery occlusion and ASPECTS 0 to 5. Among these 504 patients, 172 (34.1 %) were treated with EVT (EVT group) and 332 (65.9 %) without (no-EVT group). In the no-EVT group, elderly patients, females, poor prestroke modified Rankin Scale, high National Institutes of Health Stroke Scale, low ASPECTS, and late admission were significantly more observed. Good functional outcomes were significantly more observed in the EVT group than in the no-EVT group (19.8 % versus 4.2 %; P<0.0001; adjusted odds ratio, 2.33; 95% CI, 1.10-4.94). The incidences of symptomatic intracranial hemorrhage within 72 hours did not significantly different between the EVT group and the no-EVT group (3.7 % versus 4.9%; P=0.55; adjusted odds ratio, 0.50; 95% CI, 0.14-1.73). Conclusions-Although outcomes in this group of patients were usually poor, the data suggested EVT may increase the likelihood of a good functional outcome. (Stroke. 2019;50:901-908.
T he Alberta Stroke Program Early CT Score (ASPECTS)
is widely used as a method to evaluate the range of early ischemic change in acute cerebral infarction, 1 and in the American Heart Association guideline 2018, 2 endovascular therapy (EVT) is strongly recommended for acute cerebral large vessel occlusion (LVO) with ASPECTS ≥6 (6-10) due to occlusion of the internal carotid artery (ICA) or M1 segment of the middle cerebral artery (M1) as class of recommendation I. 2 But the benefits of EVT for patients with ASPECTS ≤5 (0-5) are uncertain, so it is recommended only as class of recommendation IIb in that guideline. In real world, EVT is sometimes performed for the patients with ASPECTS 0 to 5 because even if the early ischemic change is wide, EVT may be effective if the penumbra area is wide. 3 However, reperfusion therapy for patients with large ischemic core may increase the risk of intracranial hemorrhage. 4 In many previous randomized controlled trials (RCTs), [5] [6] [7] [8] patients with large ischemic core were excluded. For example, in the ESCAPE trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times) 5 and the SWIFT PRIME trial (Solitaire With the Intension for Thrombectomy as Primary Endovascular Treatment), 6 patients with ASPECTS <6 were excluded. In the EXTEND IA trial ( 8 those with ASPECTS <7 on noncontrast CT or magnetic resonance (MR) diffusionweighted image (DWI)-ASPECTS <6 were excluded.
However, in the MR CLEAN trial (the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), 9 regardless of ASPECTS, patients with acute stroke with extracranial carotid and intracranial arterial occlusion demonstrated by computed tomography angiography, magnetic resonance angiography, or digital subtraction angiography were included. The result could not show the effectiveness of EVT for patients with ASPECTS 0 to 4, and the point estimate for treatment effect in the subgroup of ASPECTS 0 to 4 was close to unity but with a wide CI (adjusted odds ratio [OR] 1.09; 95% CI, 0.14-8.46). The THRACE trial (Thrombectomie des Artères Cerebrales) 10 was also an RCT that included patients who had occlusion of ICA or M1 or the superior third of the basilar artery confirmed by computed tomography angiography or magnetic resonance angiography, regardless ASPECTS. In that trial, EVT for patients with ASPECTS 0 to 4 on DWI was tended to effective (adjusted OR, 1.59; 95% CI, 0.5-5.04). Furthermore, the HERMES study (the Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials), 11 a meta-analysis based on 5 RCTs (MR CLEAN, ESCAPE, REVASCAT, SWIFT PRIME, and EXTEND IA), [5] [6] [7] [8] [9] did not show the effectiveness of EVT for patients with CT-ASPECTS 0 to 5 (or in some patients DWI; crude OR, 1.24; 95% CI, 0.62-2.49). However, there are only a few studies reporting the possibility that EVT is effective for patients with large ischemic core.
The aim of the present study was to elucidate the efficacy of EVT for patients with large ischemic core in a nationwide registry of acute LVO.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request and with approval from the Recovery by Endovascular Salvage for Cerebral Ultra-Acute Embolism Japan Registry 2 (RESCUE-Japan Registry 2) investigators.
RESCUE-Japan Registry 2
Patients were identified from the RESCUE-Japan Registry 2 which was a prospective, multicenter registry enrolling consecutive 2420 patients with acute cerebral LVO in 46 centers in Japan between October 1, 2014 and September 30, 2016. 12 Briefly, we measured the extent of stroke using ASPECTS on noncontrast CT or DWI. We also classified the location of the occlusion by using either MR angiography, CT angiography, or digital subtraction angiography. Perfusion images of MR imaging (MRI) or CT were not essential. Data were recorded on a standardized electronic data capture and sent to a centralized center over a secured internet. ASPECTS was evaluated at each center, and central analysis of images was not done.
The institutional review boards of all 46 participating centers approved the protocol. Written informed consent from each patient was waived in this registry because we used clinical information obtained in routine clinical practice. The institutional review boards approved the exemption in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan. The Independent Data Safety Monitoring Board periodically reviewed the progress of this study. All study centers were regularly alerted by the study secretariat not to miss the consecutive patients with acute LVO.
This subanalysis was also approved by institutional review boards in our center, and the board waived the need for patient consent.
Sample Selection
Patients with acute ICA or M1 occlusion with pretreatment ASPECTS 0 to 5 on noncontrast CT or DWI were extracted from the data of RESCUE-Japan Registry 2. ICA occlusion included intracranial ICA and extracranial ICA, as well as tandem occlusions, such as extracranial ICA occlusion and M2 occlusion. If both NCTT and MRI were performed before treatment, DWI-ASPECTS was referred.
Outcomes
We measured the patients' disabilities using modified Rankin Scale (mRS). 13 We defined mRS 0 to 2 as good functional outcome and set it as primary outcome and evaluated it 90 days after the onset of stroke. Secondary outcomes were considered to be either National Institutes of Health Stroke Scale (NIHSS) 14, 15 score of ≥8 improvements at 24 hours after admission, an excellent functional outcome as defined by mRS ≤1 (0 to 1) at 90 days, a moderate functional outcome as defined by ≤mRS 3 (0-3) at 90 days and mortality at 90 days.
Safety outcomes included any intracranial hemorrhage (ICH) and symptomatic ICH within 72 hours after admission; they were detected by CT or MRI. We defined symptomatic ICH as one with neurological worsening more than 4 points in NIHSS. 16 
Statistical Analysis
Categorical variables were presented as numbers and percentages and were compared using the χ 2 test. Continuous variables were expressed as either mean and SD or median and interquartile range. Based on their distributions, continuous variables were compared using the Student t test or the Wilcoxon rank-sum test. Because clinical judgment was based on the qualitative not quantitative values of continuous variables, we dichotomized the continuous variables according to the clinically relevant thresholds in the analyses thereafter.
We constructed the multivariable logistic regression models by adjusting the following variables: age (<75 years or ≥75 years), ASPECTS (0-2 or 3-5), NIHSS (<16 or ≥16), prestroke mRS (<2 or ≥2), time from onset of stroke to hospital door (onset-to door; <180 minutes or ≥180 minutes), use of intravenous r-tPA (recombinant tissue-type plasminogen activator; r-tPA or no r-tPA), and ICA occlusion (ICA occlusion or only M1 occlusion). We dichotomized ages above and below 75 years based on the criteria for advanced age used by the Japanese health insurance system. 17 A retrospective study 18 of the prognostic factors of patients with DWI-ASPECTS 0 to 5 who received EVT reported that DWI-ASPECTS >2 was one of pretreatment markers of good neurological outcomes. Therefore, we dichotomized ASPECTS into 0 to 2 and 3 to 5. The threshold of NIHSS was decided as 15, because the median of NIHSS in the data of the RESCUE-Japan Registry was 15. 17 In the American Heart Association guideline 2018, 2 EVT is recommended for patients with prestroke mRS ≤1, so we determined the threshold of prestroke mRS to 1. The threshold of 180 minutes for time from stroke onset to hospital door was determined by the previous report. 19 The outcomes of EVT relative to no-EVT were expressed as ORs and 95% CIs.
For analyses of all mRS, we report unadjusted and adjusted common ORs, which were derived from ordinal logistic regression and indicated the odds that EVT might lead to improvement of ≥1 points on mRS in a shift analysis.
As a supplemental analysis, we analyzed patients with ASPECTS 6 to 10 and compared them with the analysis results of patients with ASPECTS 0 to 5. In addition, we also performed multivariable analysis including the onset-to-needle time instead of the onset-to-door time. With reference to the previous and current time limit of r-tPA administration, we dichotomized the onset-to-needle time from 0 to <180 minutes and over 180 minutes.
The subgroups for primary outcomes were: age (<75 or ≥75), r-tPA (r-tPA or no r-tPA), onset-to door (<180 or ≥180), NIHSS (<16 or ≥16), prestroke mRS (<2 or ≥2), ASPECTS (0-2 or 3-5), ICA occlusion, or only M1 occlusion.
All reported P values were 2-tailed, and P values <0.05 were considered to be statistically significant.
Results

Patients' Characteristics
A total of 2420 patients were registered in RESCUE-Japan Registry 2, and 1886 patients had ischemic lesions in anterior circulation with ASPECTS data. Among 1886 patients, 1714 patients were received MRI, 172 patients received CT only, and 532 patients were received both. Then, 504 patients with ASPECTS 0 to 5 had acute ICA or M1 occlusion. Among these 504 patients, 172 (34.1%) were treated with EVT (EVT group) and 332 (65.9%) without (no-EVT group; Figure 1 ).
In the no-EVT group, elderly patients, females, poor prestroke mRS, high NIHSS, and low ASPECTS were significantly more observed (Table 1) . However, early onset-todoor, r-tPA administration, and early onset-to-needle were significantly more observed in the EVT group. EVT tended to be performed for younger, better prestroke mRS, earlier presented, lower NIHSS, and higher ASPECTS patients. Between both groups, there was no significant difference in past medical history, vital signs at hospitalization, and occlusion site. MRI was performed for most patients in the EVT group and the no-EVT group (93.0% versus 89.2% because most of participating centers mainly performed MRI for initial diagnosis of stroke patients. By contrast, CT is the first examination for acute stroke diagnosis globally, so we tried to analyze by CT only. However, the number of patients evaluated by CT alone was too small for sufficient statistical analysis. Therefore, patients evaluated by MRI only, those evaluated by CT only, and those evaluated by both modality were analyzed collectively.
Primary Outcome
Good functional outcomes were significantly more observed in the EVT group than those in the no-EVT group (19.8% versus 4.2%; P<0.0001; adjusted OR, 2.33; 95% CI, 1.10-4.94; Table 2) .
As a supplement, we performed multivariate analysis by setting age as a continuous variable, ASPECTS, and NIHSS as ordinal variables, and the results were similar to the main results (primary outcome's adjusted OR, 2.51; Tables I and II in the online-only Data Supplement). 
Secondary Outcomes
Safety Outcomes
Among 504 patients, there were 450 patients who had been evaluated the presence or absence of ICH after treatment. The rate of any ICH and symptomatic ICH did not significantly differ in the EVT group and the no-EVT group (any ICH 33.7% versus 32.4%; P=0.77; adjusted OR, 1.14; 95% CI, 0.69-1.87, symptomatic ICH, 3.7% versus 4.9%; P=0.55; adjusted OR, 0.50; 95% CI, 0.14-1.73; Table 3 ).
Primary Outcomes in Each Imaging Modality
As mentioned above, MRI was performed in most patients in this registry, but there were many patients who were performed both CT and MRI, and the CT-ASPECTS were also obtained in 704 patients. Analysis similar to the present study was conducted for each of the CT-ASPECTS group and the DWI-ASPECTS group, and in both cases, good functional outcomes were significantly more observed in the EVT group than in the no-EVT group (the CT-ASPECTS group 16 
Primary Outcomes by Adjusting With the Onset-to-Needle Time
The number of patients with r-tPA administration was small in both the EVT group (39%) and the no-EVT group (12.4%; 
Stroke
April 2019
adjusted OR was higher in the analysis of ASPECTS 0 to 5 than in those of ASPECTS 6-10 (2.33 versus 1.81).
Shift Analysis
There was a significant difference between both groups in the overall distribution of mRS at 90 days ( Figure 2 ). We performed ordinal analysis (shift analysis) on the mRS at 90 days between both groups. In an analysis with univariable ordinal regression, common OR was 4.63 and 95% CIs were 3.23 to 6.62. In an analysis with multivariable ordinal regression after adjustment of factors likely to influence prognosis (age, NIHSS, with or without r-tPA administration, prestroke mRS, onset-to-door, ASPECTS, with or without ICA occlusion), adjusted common OR was 2.85, and 95% CIs were 1.87 to 4.34.
Subgroup Analyses
There were no significant interactions between any subgroups, except for the onset-to-door and the NIHSS group (Figure 3) .
In the subgroup of onset-to-door <180, there were significantly more good functional outcomes in the EVT group (adjusted OR, 4.86; 95% CI, 1.7-13.85), and there was a significant difference with the subgroup of onset-todoor ≥180 (interaction P values 0.02). In the subgroup of NIHSS ≥16, there were significantly more good functional outcomes in the EVT group (adjusted OR, 4.98; 95% CI, 1.9-13.05), and there was a significant difference with the subgroup of NIHSS <16 (interaction P values 0.0014). In the subgroup of prestroke mRS <2, there were significantly more good functional outcomes in the EVT group, but there was no significant difference with the subgroup of prestroke mRS ≥2. In the subgroup of age <75 years and age ≥75 years, there was a tendency that good functional outcomes were more observed in the EVT group. In the subgroup of ASPECTS 3 to 5, there was a tendency that good functional outcomes were more observed in the EVT group (adjusted OR, 2.04; 95% CI, 0.96-4.37). However, in ASPECTS 0 to 2, adjusted OR could not be calculated due to insufficient number of patients. In the subgroup of ICA occlusion, good functional outcomes were significantly more observed in the EVT group. On the other hand, in the subgroup of only M1 occlusion, those were tended to be more observed in the EVT group.
Discussion
In the present study, the patients having ICA or M1 occlusion with ASPECTS 0 to 5 on NCTT or DWI were extracted from 2420 acute LVO patients admitted within 24 hours after onset, who were registered to the nationwide registry, RESCUEJapan registry 2, and clinical outcome was compared between the EVT group and the no-EVT group. It should be noted that because this study was an analysis based on a registry, there was the issue of difficulty in adjusting for known differences in baseline characteristics by multivariable regression analysis, as well as the problem of being unable to incorporate known (eg, CT perfusion findings) or unknown (eg, frailty) variables in the analysis.
There are some reports available to show the potential of EVT to be beneficial for the patients with large ischemic core. There is a report showing better outcome of the patients with DWI-ASPECTS 0 to 6 due to acute ICA or M1 occlusion with successful reperfusion (n=145) compared with those without reperfusion (n=73). 20 Also, another small retrospective study showed that in patients having acute occlusion of anterior circulation with DWI-ASPECTS 0 to 5 (N=108), compared with the no-EVT group (n=48), in the EVT group (n=60), there were significantly more patients with mRS 0 to 2 after 90 days, and the mortality was significantly lower. 21 There was a small cohort study showing that patients with DWI-ASPECTS 0 to 6 had less benefit from EVT than patients with DWI-ASPECTS 7 or higher, but outcomes were still better than those with medication alone (patients with mRS ≥3 in 11 of 15 versus 23 of 23, respectively; P=0.019).
22
A retrospective study based on a registry having patients with DWI-ASPECTS 0 to 5 treated by EVT reported that <Adjusted factor> National Institutes of Health Stroke Scale (NIHSS) <16, age ≥75 y, r-tPA (recombinant tissue-type plasminogen activator), modified Rankin Scale before onset of stroke (prestroke mRS) 0-1, time from onset to hospitalization (onset-to-door) <180, ASPECTS (Alberta Stroke Program Early CT Score) 3-5, internal carotid artery (ICA) occlusion. EVT indicates endovascular therapy. <Adjusted factor> National Institutes of Health Stroke Scale (NIHSS) <16, age ≥75 y, r-tPA (recombinant tissue-type plasminogen activator), modified Rankin Scale before onset of stroke (prestroke mRS) 0-1, time from onset to hospitalization (onset-to-door) <180, ASPECTS (Alberta Stroke Program Early CT Score) 3-5, internal carotid artery (ICA) occlusion. EVT indicates endovascular therapy.
*NIHSS ≥4 worsening within 72 h after onset.
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DWI-ASPECTS 3 to 5 was one of markers predictive of good prognosis. 18 In the present study, in the 369 patients with ASPECTS 3 to 5, good functional outcomes were more observed in the EVT group compared with the no-EVT group (20.4% versus 6.6%; P<0.0001; adjusted OR, 2.04; 95% CI, 0.96-4.37; Figure 3 ). In contrast, in the 135 patients with ASPECTS 0 to 2, and good functional outcomes were obtained in 2 of 15 patients in the EVT group (13.3%), but not in the no-the EVT group (0%). Adjusted OR could not be calculated due to insufficient number of patients.
Onset-to-door time was significantly shorter in the EVT group than in the no-EVT group (110; 95% CI, 50-195 versus 270; 95% CI, 110-656.3), and significantly more patients received r-tPA therapy in the EVT group (39.0% versus 12.4%; Table 1 ). Many physicians might have selected aggressive treatments by r-tPA and EVT for patients with early arrival. However, good functional outcomes were more observed in the patient treated by EVT regardless of r-tPA therapy (Figure 3 ). ASPECTS score is not only associated with the size of infarct core and stroke severity but is also highly depended on the elapsed time from stroke onset, as evident by the significant difference of onset-to-door times between the EVT group and the no-EVT group (110; 95% CI, 50-195 versus 270; 95% CI, 110-656.3; Table 1 ). Thus, time from stroke onset seemed one of the most important factors to treat by EVT in the case with large ischemic core.
Patients in the EVT group were younger than those in the no-EVT group. However, good functional outcomes were more observed in the EVT group even in 75 years or older patients (Figure 3 ). However, good functional outcomes were significantly more in the EVT group in NIHSS ≥16 and not in NIHSS <16. The benefits of EVT may be greater in patients with higher baseline NIHSS. Another interesting point was that good functional outcomes were significantly more seen in the EVT group with ICA occlusion, but not with M1 occlusion alone.
There has been a concern that hemorrhagic event is caused by EVT when the patients have large ischemic core, 4 but the present study showed no increase of hemorrhage in the EVT group (Table 3) . Although EVT is currently recommended for patients with ASPECTS 6 to 10, 2 the present study showed that EVT was associated with better outcomes even in the patients with large ischemic core.
Limitations
The present study had several limitations. First, this study was a subanalysis of a nationwide multicenter registry, so the indication of EVT was different by institutions or physicians. For example, compared with the EVT group, elderly patients, poor prestroke mRS, high NIHSS, low ASPECTS, less r-tPA administration, and late admission were significantly more observed in the no-EVT group ( Table 1 ), suggesting that these factors influenced physicians' judgment to apply EVT or not. Also, it is likely there were unrecorded patients' characteristics (eg, multimorbidity and frailty) that impact on outcome and influenced the decision to treat. Because of a registry, it is difficult to remove these confounders completely. Therefore, we started a new RCT to test the efficacy of EVT for patients with large ischemic core (https://www.clinicaltrials.gov. Unique identifier: NCT03702413) based on the findings of the present study. Second, we registered patients with acute LVO for 2 years from 46 hospitals, and this is the largest study to date. However, the sample size was not enough to evaluate patients with very low ASPECTS. Third, the method of image examination was not standardized in the study group, and central analysis of images was not done. Fourth, because most patients in the present study were evaluated by MRI, it is uncertain whether the result can be applied to CT-ASPECTS. Fifth, perfusion imaging is a major confounder, and MRI or CT perfusion parameters should have influenced the decision to proceed to EVT. However, perfusion imaging was not essential in this registry. Recently, it has become a trend to measure the volume of ischemic core using software such as rapid processing of perfusion and diffusion (RAPID) system. 23, 24 Although such imaging software is not approved in our country, the ischemic core volume should be analyzed in our new RCT. Finally, mRS evaluation could be biased because the methods of treatments of the patients were not masked, although evaluation was performed by independent physicians. However, the mortality was less likely to be biased, and it was reduced by EVT.
Conclusions
Our large prospective registry of acute LVO patients suggested that outcomes of patients with large ischemic core were usually poor, but the data suggested EVT may increase the likelihood of good functional outcomes. It is necessary to elucidate effectiveness of EVT for those patients by RCTs in the near future.
